[Treatment of high-risk leukaemia: allograft and immunotherapy]. / Traitement des leucémies à haut risque : allogreffe et immunothérapie.

ABSTRACT

Leukaemia results from a malignant proliferation of cells in the bone marrow. The prognosis is defined by the disease's biological characteristics. Treatment is based on chemotherapy. In cases of high-risk leukaemia, an allograft may be proposed. The arrival of targeted therapies and immunotherapy has revolutionised the prognosis of the disease. The challenge of the next few years will be to define the place of these therapies.